Correspondence 0001104659-24-067860 from Structure Therapeutics Inc. (GPCR) (CIK 0001888886) (GPCR)
Structure Therapeutics Inc. (GPCR) (CIK 0001888886)
Date: June 3, 2024 · CIK: 0001888886 · Accession: 0001104659-24-067860
AI Filing Summary & Sentiment
File numbers found in text: 333-279915
Letter
Structure Therapeutics Inc.
601 Gateway Blvd., Suite 900
South San Francisco, CA
June 3,
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
RE: Structure Therapeutics Inc.
Registration Statement on Form S-1
Filed June 3, 2024
File No. 333-279915
Acceleration Request
Requested Date: June 5, 2024
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, Structure Therapeutics, Inc. (the “Company”) hereby requests that the Securities and Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern time, on June 5, 2024, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone to the staff of the Commission. The Company hereby authorizes each of Patrick Loofbourrow and Jean Park of Cooley LLP, counsel to the Company, to make such a request on its behalf. This request for acceleration is subject, however, to your receiving a telephone call prior to such time from Cooley LLP confirming this request.
Once the Registration Statement has been declared effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Jean Park of Cooley LLP at (212) 479-6131.
Under separate cover, you will receive today a letter from the managing underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration Statement.
[Signature Page Follows]
Sincerely,
Structure Therapeutics Inc.
Show Raw Text
CORRESP
1
filename1.htm
Structure Therapeutics
Inc.
601 Gateway Blvd., Suite 900
South San Francisco, CA
94080
June 3,
2024
VIA EDGAR
U.S. Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Attn: Joshua Gorsky
RE:
Structure Therapeutics Inc.
Registration Statement on Form S-1
Filed June 3, 2024
File No. 333-279915
Acceleration Request
Requested Date: June 5, 2024
Requested Time: 4:00 p.m. Eastern Time
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities
Act of 1933, as amended, Structure Therapeutics, Inc. (the “Company”) hereby requests that the Securities and
Exchange Commission (the “Commission”) accelerate the effective date of the above-referenced Registration Statement
on Form S-1 (the “Registration Statement”) and declare the Registration Statement effective as of 4:00 p.m. Eastern
time, on June 5, 2024, or as soon thereafter as possible, or at such other time as the Company or its counsel may request by telephone
to the staff of the Commission. The Company hereby authorizes each of Patrick Loofbourrow and Jean Park of Cooley LLP, counsel to the
Company, to make such a request on its behalf. This request for acceleration is subject, however, to your receiving a telephone call prior
to such time from Cooley LLP confirming this request.
Once the Registration Statement has been declared
effective, please orally confirm that event with Patrick Loofbourrow of Cooley LLP at (619) 840-4824, or in his absence, Jean Park of
Cooley LLP at (212) 479-6131.
Under separate cover, you will receive today a letter from the managing
underwriters of the proposed offering joining in the Company’s request for acceleration of the effectiveness of the Registration
Statement.
[Signature Page Follows]
Sincerely,
Structure Therapeutics Inc.
By:
/s/ Raymond Stevens
Raymond Stevens, Ph.D.
Chief Executive Officer